Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Biotech Industry Analysis

UpdatedJul 11, 2025
DataAggregated Company Financials
Companies5
  • 7D1.8%
  • 3M33.3%
  • 1Y48.7%
  • YTD12.4%

The Biotech industry is up 1.8% in the last week, with Basilea Pharmaceutica up 3.0%. This means that the industry has gained 49% over the past year. Looking forward, earnings are forecast to decline by 10% per year.

Industry Valuation and Performance

Has the Swiss Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 12 Jul 2025CHF 2.0bCHF 333.9m-CHF 44,705,000.007.6x-43.7x5.9x
Mon, 09 Jun 2025CHF 1.9bCHF 333.9m-CHF 44,705,000.008x-42.1x5.6x
Wed, 07 May 2025CHF 1.9bCHF 336.6m-CHF 39,259,000.006.9x-47.5x5.5x
Fri, 04 Apr 2025CHF 1.5bCHF 409.3m-CHF 35,110,868.004.8x-43.6x3.7x
Sun, 02 Mar 2025CHF 1.8bCHF 387.3m-CHF 48,828,868.005.3x-37.1x4.7x
Tue, 28 Jan 2025CHF 1.7bCHF 330.3m-CHF 75,131,868.003.1x-22.7x5.2x
Thu, 26 Dec 2024CHF 1.6bCHF 330.9m-CHF 87,805,465.002.2x-18.5x4.9x
Sat, 23 Nov 2024CHF 1.8bCHF 331.2m-CHF 86,988,629.001.5x-20.2x5.3x
Mon, 21 Oct 2024CHF 1.8bCHF 333.1m-CHF 82,023,629.001.8x-21.6x5.3x
Wed, 18 Sep 2024CHF 1.6bCHF 333.6m-CHF 81,088,264.001.7x-19.3x4.7x
Fri, 16 Aug 2024CHF 810.6mCHF 170.7m-CHF 141,356,264.001.9x-5.7x4.7x
Sun, 14 Jul 2024CHF 758.3mCHF 151.7m-CHF 146,197,264.001.4x-5.2x5x
Tue, 11 Jun 2024CHF 624.2mCHF 169.3m-CHF 139,094,874.120.9x-4.5x3.7x
Thu, 09 May 2024CHF 485.7mCHF 171.0m-CHF 134,962,367.901x-3.6x2.8x
Sat, 06 Apr 2024CHF 382.6mCHF 67.4m-CHF 173,193,075.500.1x-2.2x5.7x
Mon, 04 Mar 2024CHF 360.1mCHF 55.6m-CHF 173,212,672.720.2x-2.1x6.5x
Wed, 31 Jan 2024CHF 377.8mCHF 317.6m-CHF 176,007,021.001.1x-2.1x1.2x
Fri, 29 Dec 2023CHF 288.1mCHF 317.2m-CHF 176,181,463.000.6x-1.6x0.9x
Sun, 26 Nov 2023CHF 304.1mCHF 318.1m-CHF 210,673,204.00n/a-1.4x1x
Tue, 24 Oct 2023CHF 252.0mCHF 318.1m-CHF 212,843,042.00n/a-1.2x0.8x
Thu, 21 Sep 2023CHF 274.7mCHF 318.5m-CHF 219,022,560.00n/a-1.3x0.9x
Sat, 19 Aug 2023CHF 509.0mCHF 325.8m-CHF 175,785,222.00n/a-2.9x1.6x
Mon, 17 Jul 2023CHF 315.7mCHF 320.3m-CHF 179,703,342.00n/a-1.8x1x
Wed, 14 Jun 2023CHF 320.9mCHF 333.9m-CHF 181,118,746.00n/a-1.8x1x
Fri, 12 May 2023CHF 369.7mCHF 498.9m-CHF 18,561,621.001.7x-19.9x0.7x
Sun, 09 Apr 2023CHF 407.2mCHF 485.0mCHF 12.4m1.5x32.8x0.8x
Tue, 07 Mar 2023CHF 485.5mCHF 493.4mCHF 14.5m1.7x33.5x1x
Thu, 02 Feb 2023CHF 497.0mCHF 493.4mCHF 14.5m1.6x34.3x1x
Sat, 31 Dec 2022CHF 485.3mCHF 493.4mCHF 14.5m1.7x33.5x1x
Mon, 28 Nov 2022CHF 515.0mCHF 493.4mCHF 14.5m1.7x35.5x1x
Wed, 26 Oct 2022CHF 522.5mCHF 509.3mCHF 15.9m2x32.9x1x
Fri, 23 Sep 2022CHF 519.3mCHF 505.5mCHF 15.9m1.9x32.6x1x
Sun, 21 Aug 2022CHF 518.2mCHF 486.5mCHF 36.1m1.9x14.3x1.1x
Tue, 19 Jul 2022CHF 528.7mCHF 491.7mCHF 42.2m1.8x12.5x1.1x
Price to Earnings Ratio

12.5x


Total Market Cap: CHF 528.7mTotal Earnings: CHF 42.2mTotal Revenue: CHF 491.7mTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Biotech Industry Price to Earnings3Y Average -1.3x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 3.0x is lower than the industry's current PS ratio of 5.9x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 12% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market1.46%
Healthcare2.52%
Biotech1.77%
Biotech1.77%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BSLN Basilea PharmaceuticaCHF 48.203.0%
+CHF 17.2m		17.4%PE7.6x
KURN Kuros BiosciencesCHF 28.280.6%
+CHF 6.9m		128.8%PS14.4x
IDIA IdorsiaCHF 2.351.1%
+CHF 5.1m		5.3%PS3x
SANN Santhera Pharmaceuticals HoldingCHF 12.201.3%
+CHF 2.1m		45.4%PS4x
RLF Relief Therapeutics HoldingCHF 2.244.2%
+CHF 1.1m		87.4%PS3.3x

Latest News

BSLN
CHF 48.20
Basilea Pharmaceutica
7D
3.0%
1Y
17.4%
MOLN
CHF 2.89
Molecular Partners
7D
-2.5%
1Y
-51.2%
RLF
CHF 2.24
Relief Therapeutics Holding
7D
4.2%
1Y
87.4%
IDIA
CHF 2.35
Idorsia
7D
1.1%
1Y
5.3%
SANN
CHF 12.20
Santhera Pharmaceuticals Holding
7D
1.3%
1Y
45.4%
KURN
CHF 28.28
Kuros Biosciences
7D
0.6%
1Y
128.8%

Kuros Biosciences AG (VTX:KURN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Apr 29
Kuros Biosciences AG (VTX:KURN) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected